Document is current
Any future updates will be listed below
-
Authors
Panchal, Kunjal
Armitage, Jesse
Cheung, Laurence C.
Kotecha, Rishi S.
Malinge, Sébastien
-
Funding
Funding for this research was provided by:
Australian Government Research Training Program
Rachel Kierath Foundation
Tour de Cure
National Health and Medical Research Council of Australia (APP2033152)
Cancer Council Western Australia
Jerome Lejeune Foundation
Leukemia and Lymphoma society
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 6 September 2025
First Online: 18 September 2025
Declarations
:
: RSK discloses advisory board participation for Jazz Pharmaceuticals, Amgen and Link Healthcare.
: The authors declare no competing interests.
